Current medical guidelines discourage the use of combined oral contraceptives (COCs) among people who experience migraine with aura—a type of migraine accompanied by temporary neurological symptoms—due to a heightened risk for stroke. Despite these concerns, a notable percentage of people diagnosed with migraine with aura are still receiving prescriptions for these oral contraceptives, according to a new study led by Boston University School of Public Health (BUSPH) researchers.
This article was originally published on MedicalXpress.com

